Tenet Healthcare Corporation $THC Shares Sold by Ameritas Investment Partners Inc.

Ameritas Investment Partners Inc. decreased its holdings in Tenet Healthcare Corporation (NYSE:THC) by 8.5% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 28,457 shares of the company’s stock after selling 2,648 shares during the quarter. Ameritas Investment Partners Inc.’s holdings in Tenet Healthcare were worth $5,778,000 as of its most recent filing with the SEC.

Several other institutional investors have also bought and sold shares of the stock. Boston Partners increased its stake in Tenet Healthcare by 95.0% during the 2nd quarter. Boston Partners now owns 2,267,142 shares of the company’s stock valued at $398,949,000 after buying an additional 1,104,500 shares during the period. Ameriprise Financial Inc. boosted its holdings in shares of Tenet Healthcare by 8.0% in the second quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock valued at $373,020,000 after acquiring an additional 157,109 shares in the last quarter. Norges Bank bought a new stake in Tenet Healthcare during the second quarter worth approximately $206,981,000. AQR Capital Management LLC lifted its position in Tenet Healthcare by 28.0% in the second quarter. AQR Capital Management LLC now owns 1,156,263 shares of the company’s stock worth $200,224,000 after purchasing an additional 252,993 shares during the period. Finally, Alliancebernstein L.P. boosted its stake in Tenet Healthcare by 375.7% during the 2nd quarter. Alliancebernstein L.P. now owns 790,254 shares of the company’s stock valued at $139,085,000 after purchasing an additional 624,125 shares in the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

Insider Transactions at Tenet Healthcare

In related news, Director Nadja West sold 2,178 shares of Tenet Healthcare stock in a transaction on Monday, December 15th. The stock was sold at an average price of $197.47, for a total transaction of $430,089.66. Following the completion of the sale, the director owned 28,480 shares of the company’s stock, valued at approximately $5,623,945.60. This trade represents a 7.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.81% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on THC shares. Cantor Fitzgerald upped their price objective on Tenet Healthcare from $190.00 to $245.00 and gave the company an “overweight” rating in a report on Wednesday, October 29th. JPMorgan Chase & Co. upped their price target on shares of Tenet Healthcare from $200.00 to $230.00 and gave the company an “overweight” rating in a report on Thursday, November 13th. KeyCorp boosted their target price on shares of Tenet Healthcare from $225.00 to $250.00 and gave the stock an “overweight” rating in a report on Thursday, February 12th. Jefferies Financial Group raised their target price on shares of Tenet Healthcare from $250.00 to $265.00 and gave the stock a “buy” rating in a report on Thursday, February 12th. Finally, Wall Street Zen cut Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $247.67.

Tenet Healthcare Price Performance

Shares of THC opened at $229.56 on Friday. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68. The company has a market capitalization of $19.96 billion, a price-to-earnings ratio of 14.82, a P/E/G ratio of 1.13 and a beta of 1.44. The business’s 50-day moving average is $201.87 and its 200-day moving average is $197.42. Tenet Healthcare Corporation has a fifty-two week low of $109.82 and a fifty-two week high of $235.77.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, beating the consensus estimate of $4.08 by $0.62. The firm had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The company’s revenue for the quarter was up 8.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Equities research analysts expect that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.